Skip to main content
Menu
US

HTRF α-Synuclein Aggregation Kit, 500 Assay Points

This HTRF kit is designed for an accurate quantitative measurement of alpha synuclein aggregation in brain extracts.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Protein Quantification
Sample Volume 10 µL

This HTRF kit is designed for an accurate quantitative measurement of alpha synuclein aggregation in brain extracts.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Unit Size: 500 Assay Points
Part #:
6FASYPEG
List Price
USD 1,603.00
Unit Size: 10,000 Assay Points
Part #:
6FASYPEH
List Price
USD 18,890.00

Overview

Monitoring alpha-synuclein aggregation is of great interest for studying the pathogenesis of synucleinopathies, a group of neurodegenerative diseases that includes Parkinson's disease (PD), dementia with Lewy bodies (DLB), diffuse Lewy body disease (DLBD), and multiple system atrophy (MSA). The kit provides a solution to rapidly detect and quantify protein aggregates of human alpha-synuclein in cell culture or brain tissue extracts.

Specifications

Application
Protein Quantification
Brand
HTRF
Detection Modality
HTRF
Product Group
Kit
Sample Volume
10 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Biomarkers
Technology
TR-FRET
Therapeutic Area
Neuroscience
Unit Size
500 Assay Points

Video gallery

Citations

How it works

Assay principle

Alpha-Synuclein aggregates are measured using a sandwich immunoassay involving an anti-a Synuclein monoclonal antibody specific for alpha-Synuclein aggregate labelled with terbium-Cryptate or d2, ensuring assay quality, reproducibility, and signal quality. The specific HTRF signal generated is proportional to the alpha-Synuclein aggregates.

biomarkers-how-it-works-assay-principle-alpha-synuclein-aggregation-6fasypeg-6fasypeh
Assay Protocol

The sample or brain extracts are transferred to the assay plate for the detection of a-Synuclein aggregates. The antibodies labelled with HTRF fluorophores may be pre-mixed and added in a single dispensing step to further streamline the assay procedure. The assay detection can be run in 96- to 384-well plates by simply resizing each addition volume proportionally.

biomarkers-how-it-works-assay-protocol-alpha-synuclein-aggregation-6fasypeg-6fasypeh

 

Assay validation

Alpha synuclein aggregation in human brain samples

Samples from human putamen (Parkinson's versus control) were collected and lysed with a Revvity lysis buffer. Due to the nature of the samples, the conventional cellular protocol needed to be adjusted. Incubation was performed for 20 hours at RT. Even at high dilution (1/64), clear discrimination between the two sample types is possible with Revvity's aggregated alpha synuclein assay.

assay-validation-alpha-synuclein-aggregation-1

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Whitepaper Icon
Whitepaper
Targeted protein degradation: A novel therapeutic strategy for neurodegenerative diseases

Targeted protein degradation (TPD) offers a promising approach for treating neurodegenerative diseases by selectively degrading...

Scroll Icon